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Abstract 
Purpose To provide a commentary on “The use of cognitive behaviour therapy to treat depression in 
people with learning disabilities: a systematic review”.  
Design/Methodology/Approach  Drawing on the literature, as well as both clinical and research 
experience, some reasons are outlined for the lack of attention given to psychological therapies to 
treat depression amongst people with intellectual disabilities.  
Findings More research is needed, but existing evidence is promising regarding the effectiveness of 
adapted cognitive behaviour therapy for depression amongst people with intellectual disabilities. 
Originality/Value The commentary draws attention to the scope for developing a range of effective 
cognitive, behavioural and cognitive-behavioural treatments.  
Key words: Learning disability, intellectual disability, cognitive behaviour therapy, depression, 
behavioural activation, meta-analysis 
 
 
In 2013, we undertook a meta-analysis of psychological therapies, concluding that cognitive 
behavioural therapy appeared to be efficacious when used with people who have intellectual 
disabilities (IDs), reporting an overall effect size, g = .682 (Vereenooghe & Langdon, 2013).   The 
majority of studies included within our meta-analysis aimed to provide cognitive behavioural 
therapy for anger and aggression, while only three studies (Hassiotis et al., 2013; McCabe, 
McGillivray, & Newton, 2006; McGillivray, Lau, Cummins, & Davey, 2009) aimed to treat depression, 
with an associated effect size calculation of, g = .742.   
Historically, “talking therapies” have often been seen as inappropriate for people with IDs, with 
many making reference to Bender (1993), who wrote about people with IDs being viewed with 
“therapeutic disdain”.   Such a stigmatising view is exceptionally inappropriate, and while there has 
been a slow increase in the number of studies examining whether cognitive behavioural therapy is 
beneficial for people with IDs, we still do have some way to go before we have a robust evidence 
base.  
There are a variety of reasons why psychological therapy research with people who have IDs has 
lagged behind similar research with people who do not have IDs.  Many may still think that “talking” 
psychological therapies are unlikely to benefit some people with IDs because they may have 
difficulty understanding the concepts taught.  In order to improve accessibility, adaptations are 
often made, including the simplification of therapeutic methods, including the use of pictures, 
symbols, easier to read homework tasks, along with the use of both directive and flexible methods 
(Hamelin, Travis, & Sturmey, 2013; Hurley, Tomasulo, & Pfadt, 1998; Prout & Nowak-Drabik, 2003; 
Stenfert-Kroese, Dagnan, & Loumidis, 1997; Whitehouse, Tudway, Look, & Kroese, 2006).   However, 
we still know little about whether many of these adaptations lead to improved outcomes for people 
with IDs, and as pointed out by Vereenooghe and Langdon (2013), many of these adaptations are 
idiographic, but nevertheless, formulation driven. 
Additionally, there has been a lack of investment in funding for psychological therapy trials involving 
people with IDs, although this has been improving.  Related to this, people with IDs are often 
explicitly excluded from clinical trials of psychological therapies because assumptions are made that 
the interventions are inappropriate, ignoring whether it may be possible to make some reasonable 
adjustments to improve accessibly, and ignoring opportunities to investigate these adaptations and 
how they relate to treatment outcome.   Other issues need to be considered when recruiting people 
with IDs into clinical trials, including the role of “gatekeepers”.  Carers often make the initial decision 
whether someone with IDs can be approached and invited to take part in research, and occasionally, 
this may mean that some people may not be afforded the opportunity to take part in clinical 
research.   Issues about whether people with IDs understand the consent and randomisation process 
are highly relevant, often leading to the exclusion of people who lack capacity from psychological 
therapy trials.  The Mental Capacity Act (2005), which would apply to psychological therapies trials, 
rather than a clinical trial of an investigational medicinal product, states that research involving 
those who do not have capacity to consent must be connected with an impairing condition affecting 
research participants who are unable to consent, or with the treatment of the condition, and 
researchers must consider whether the study could be carried out effectively with only those who 
are able to give consent.   It is important ask whether researchers in England and Wales are explicitly 
excluding people who do not have capacity to consent from research in order to avoid the 
regulations set out in the Mental Capacity Act (2005) because of the perceived burden?   
Inadvertently, are these regulations leading to the exclusion of people with IDs from clinical trials of 
psychological therapies?   
While there are a variety of reasons why psychological therapy research with people who have IDs 
has lagged behind, more recently, there has been a shift to consider whether psychological therapies 
that rely less on cognitive strategies are likely to be beneficial for the treatment of depression 
amongst people with IDs.   There is robust evidence that behavioural activation is effective in the 
treatment of depression, with effect sizes ranging from .70 to .87 (Cuijpers, van Straten, & 
Warmerdam, 2007; Ekers, Richards, & Gilbody, 2008; Ekers et al., 2014; Mazzucchelli, Kane, & Rees, 
2009), and this is not dissimilar from effect sizes for cognitive-behavioural therapy.  Behavioural 
activation is a psychological treatment for depression that involves identifying a client’s values and 
goals and increasing meaningful activity related to these values and goals, which may encompass 
goals about education, employment, relationships, hobbies and leisure.  The theoretical basis of 
behavioural activation is that a lack of activity and withdrawal, or in other words, behavioural 
avoidance, are used to avoid environments that may be aversive. However, this reduces 
opportunities for positive reinforcement and maintains depression.  Within treatment, the therapist 
and patient work together to increase activities that are associated with positive reinforcement, 
leading to improvements in mood and symptoms of depression.   
Behavioural activation is recommended by the National Institute for Health and Care Excellence 
(National Institute for Health and Care Excellence, 2009), and has been shown to be superior to 
general brief or supportive psychotherapy for people with depression (Cuijpers et al., 2007; Ekers et 
al., 2008).  It is a core treatment delivered within the Improving Access to Psychological Therapies 
(IAPT) programme in England, and there is recent evidence from a small trial that behavioural 
activation can be successfully delivered by experienced generic mental health workers (Ekers, 
Richards, McMillian, Bland, & Gilbody, 2011).    There is currently a funded multicentre single blind 
randomised control trial of behavioural activation compared to a guided self-help interventions for 
depression amongst people with IDs underway (BEAT-IT Trial - HTA Reference 10/104/34), led by 
Professor Andrew Jahoda at the University of Glasgow, which will add substantially to the evidence 
base relating to the use of psychological interventions for the treatment of depression amongst 
people with IDs.   Recently, McGillivray and Kershaw (2015), attempted to compare cognitive, 
behavioural, and cognitive-behavioural interventions for depression amongst people with IDs, 
reporting no significant differences between the interventions in terms of treatment outcomes, 
although those who had received the cognitive-behavioural intervention reported fewer negative 
automatic thoughts.  
Moving forward into the future, Vereenooghe and Langdon (2013) made several recommendations 
for clinical trials involving people with IDs.  They stated that researchers should report the Full Scale 
IQ of participants, and fully described their methods and interventions, in order to help address 
heterogeneity, especially when conducted meta-analytic work.  Researchers also need to describe 
fully any adaptations that have been made to improve accessibility, and we do need more 
experimental studies examining whether changes to therapy actually lead to improved outcomes.  
Finally, we continue to need more clinical trials of psychological therapies involving people with IDs, 
including both children and adolescents, as well as people with severe to profound IDs, a population 
that is very much overlooked.   
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